Abstract: Binding of 1‐[1‐(2‐[3H]thienyl)cyclohexyl]piperidine ([3H]TCP) to mouse brain and spinal cord membranes was studied using compounds selective for the NMDA‐coupled 1‐(1‐phenylcyclohexyl)piperidine (PCP) and/or σ recognition sites. In both tissues, [3H]TCP labeled two populations of binding sites. Density of the low‐affinity sites was approximately the same in both tissues, but the population of the high‐affinity [3H]TCP sites was three times bigger in the brain than in the spinal cord. Self‐ and cross‐displacement studies showed that the high‐affinity [3H]TCP binding sites could be identical with NMDA receptor‐coupled PCP sites, whereas the low‐affinity [3H]TCP sites may be associated with σ binding sites in both tissues. The NMDA‐coupled PCP sites labeled in the presence of 6.25 nM [3H]TCP constituted a much higher percentage of the total binding in the brain (75%) than in the spinal cord (44%). Consistent with this, reintroduction of glycine and glutamate significantly increased, but DA antagonists significantly inhibited [3H]TCP binding in the brain but not in the spinal cord. Together, these data suggest that a large component of [3H]TCP‐labeled binding sites in the spinal cord may be associated with σ but not the NMDA receptor‐coupled PCP sites.
|Original language||English (US)|
|Number of pages||9|
|Journal||Journal of Neurochemistry|
|State||Published - Nov 1994|
- 1‐[1‐(2‐[H]Thienyl)cyclohexyl]piperidine binding
- Spinal cord
- σ Sites